|
|
| (3 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | | __NOTOC__ |
| ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Quinapril|{{fontcolor|#6C7B8B|Quinapril}}]]'''''
| | {{CMG}}; {{AE}} {{AZ}}, {{AM}} |
| |-
| | |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ACCUPRIL<sup>®</sup> FDA Package Insert
| | '''''For patient information about Quinapril, click [[Quinapril (patient information)|here]].''''' |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril indications and usage|Indications and Usage]]
| | ===''Quinapril''=== |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril dosage and administration|Dosage and Administration]]
| | * [[Quinapril tablet]] |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril contraindications|Contraindications]]
| | ===''Quinapril and Hydrochlorothiazide tablet''=== |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril warnings and precautions|Warnings and Precautions]]
| | * [[Quinapril and Hydrochlorothiazide tablet]] |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril adverse reactions|Adverse Reactions]]
| | ==Overview== |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril drug interactions|Drug Interactions]]
| | '''Quinapril''' tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of [[hypertension]], [[heart failure]], left ventricular dysfunction after [[myocardial infarction]], [[diabetic nephropathy]]. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. [[hypotension]], [[rash]], [[hyperkalemia]], disorder of taste, [[cough]]. |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril use in specific populations|Use in Specific Populations]]
| | ==Category== |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril overdosage|Overdosage]]
| | Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril description|Description]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril clinical pharmacology|Clinical Pharmacology]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril clinical studies|Clinical Studies]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril how supplied storage and handling|How Supplied/Storage and Handling]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril patient counseling information|Patient Counseling Information]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Quinapril labels and packages|Labels and Packages]]
| |
| |-
| |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Quinapril
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
| |
| |-
| |
| |}
| |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]
For patient information about Quinapril, click here.
Quinapril
Quinapril and Hydrochlorothiazide tablet
Overview
Quinapril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.